Publications and Articles

TB and HIV Research (the latest from the past 3 months)

Recurrent Tuberculosis: Relapse, Reinfection, and HIV
Chaisson RE, Churchyard GJ.
J Infect Dis. 2010 Feb 1.

Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil
Cavalcante SC, Durovni B, Barnes GL, Souza FB, Silva RF, Barroso PF, Mohan CI, Miller A, Golub JE, Chaisson RE.
Int J Tuberc Lung Dis. 2010 Feb 14.

Incidence of tuberculosis and HIV and progression of silicosis and lung function impairment among former Basotho gold miners
Park HH, Girdler-Brown BV, Churchyard GJ, White NW, Ehrlich RI.
Am J Ind Med. 2009 Dec;52(12):901-8.

HIV infection does not affect active case finding of tuberculosis in South African gold miners
Lewis JJ, Charalambous S, Day JH, Fielding KL, Grant AD, Hayes RJ, Corbett EL, Churchyard GJ.
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1271-8

Screening and preventive therapy for tuberculosis
Marais BJ, Ayles H, Graham SM, Godfrey-Faussett P.
Clin Chest Med. 2009 Dec;30(4):827-46, x

The fourth I: scaling up implementation of collaborative TB-HIV activities to protect vulnerable mothers and infants
Gie RP, Beyers N.
Int J Tuberc Lung Dis. 2009 Dec;13(12):1443.

TB and HIV Research - 2009

Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population
Kariminia A, Sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M, Ramezani A.

Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay Results
Pollock N, Kashino S, Napolitano D, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A.

Approaches to tuberculosis screening and diagnosisin people with HIV in resource-limited settings
Reid M, Shah NS.

Biomarkers for tuberculosis disease activity, cure, and relapse
Wallis R, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A

How research can help control tuberculosis
Chaisson RE, Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland
Harrington M., Treatment Action Group, New York.

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE.

Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory.
Muyoyeta M, Schaap JA, De Haas P, Mwanza W, Muvwimi MW, Godfrey-Faussett P, Ayles H.

No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa.
Kritzinger FE, den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, Gie RP, Beyers N.

Approaches to tuberculosis screening and diagnosisin people with HIV in resource-limited settings
Reid M, Shah NS.

Biomarkers for tuberculosis disease activity, cure, and relapse
Wallis R, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A.

Human genetic influence on susceptibility of tuberculosis: from infection to disease.
Cheepsattayakorn A, Cheepsattayakorn R.
J Med Assoc Thai. 2009 Jan;92(1):136-41.

National Expansion of Antiretroviral Treatment in Thailand, 2000-2007: Program Scale-Up and Patient Outcomes.
Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, Thanprasertsuk S, Mock PA, Ningsanond P, Lertpiriyasuwat C, Pinyopornpanich S.
J Acquir Immune Defic Syndr. 2009 Feb 13. [Epub ahead of print]

Intensified Tuberculosis Case Finding Among HIV-Infected Persons From a Voluntary Counseling and Testing Center in Addis Ababa, Ethiopia.
Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, Melaku Z, Mengistu Y, Lemma E, Wells CD, Wuhib T, Nelson LJ.
J Acquir Immune Defic Syndr. 2009 Feb 13. [Epub ahead of print]

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.
David W Dowdy & Richard E Chaisson
Center for Tuberculosis Research, Johns Hopkins University
Bull World Health Organ 2009; Feb 10

Tuberculosis incidence among contacts of active pulmonary tuberculosis.
Cailleaux-Cezar M, de A Melo D, Xavier GM, de Salles CL, de Mello FC, Ruffino-Netto A, Golub JE, Efron A, Chaisson RE, Conde MB.
Int J Tuberc Lung Dis. 2009 Feb 13

RECENT PUBLICATIONS FROM THE CREATE PROJECTS

	THRio
	Thibela
	ZAMSTAR

CREATE's NEWS ARTCLES BY YEAR

2009

Agency Doubles Number with HIV and TB - The Washington Post

Novel TB Regimen May Allow Shorter Treatment - MedPage Today

Double Trouble on World TB Day - Science Magazine

Africa: IPT Encouraged for TB Sufferers Living with HIV - All Africa News

WHO Doubles Number with HIV and TB - EuroNews 24

Health: HIV/TB Convergence Sparks Call for New Strategy - IPS News

2008

AFRICA EXPERIENCING WORST TUBERCULOSIS EPIDEMIC IN 60 YEARS, EXPERTS REPORT

CONSORTIUM TO RESPOND EFFECTIVELY TO THE AIDS/TUBERCULOSIS EPIDEMIC GETS $32 MILLION BOOST FROM BILL & MELINDA GATES FOUNDATION

On October 14, 2008, CREATE, along with the Treatment Action Group (TAG) held a press conference in Paris, France to announce that the Bill and Melinda Gates Foundation awarded CREATE with a supplement of US$32 million to continue support of CREATE's three studies. The press conference also reported on the decline of TB resources in 2008. Below is the press coverage related to the media briefing held in Paris.

Treatment Action Group Releases Report Documenting TB Funding Shortfall - From Kaiser Network

Calls for increased funding made at major TB conference - From Tropika

Decreased TB Funding Could Hinder HIV/AIDS Efforts, Researchers Say - From AllAfrica.com

Decreased TB Funding Could Hinder HIV/AIDS Efforts, Researchers Say - From Medical News Today

Decreased TB Funding Could Hinder HIV/AIDS Efforts - From Emax Health

Drop in TB funding could set back fight against AIDS - From the Los Angeles Times

Appeal by the Experts: Funding for the fight against tuberculosis falls at “alarming” rate - From EL MUNDO

Gates Foundation supporting NGO CREATE - From Agence Presse Medical

The NGO Treatment Action Group fears a slowdown in R&D funding in the field of Tuberculosis - From Agence Presse Medical

Radio France International Report on TB

Group reveals stark TB funding shortfall - From Africa Science News Service

Group Focusing on HIV-Related TB Obtains $32M from Gates Foundation - From Genetic Engineering and Biotechnology News